Long-term intermittent hypoxia in mice: Protracted hypersomnolence with oxidative injury to sleep-wake brain regions

Sleep

Volumn 27, Issue 2, 2004, Pages 194-201

  Veasey, Sigrid Carlen ^a,b   Davis, Christine W ^a   Fenik, Polina ^a   Zhan, Guanxia ^a   Hsu, Yeou Jey ^a   Pratico, Domenico ^a   Gow, Andrew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apnea; Hypoxia; Oxidation; Oxidative stress; Wakefulness

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HYPOXIA; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME; SLEEP WAKING CYCLE; SOMNOLENCE; ANIMAL; BRAIN HYPOXIA; C57BL MOUSE; CIRCADIAN RHYTHM SLEEP DISORDER; ELECTRODE; FOREBRAIN; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DISORDERS OF EXCESSIVE SOMNOLENCE; ELECTRODES, IMPLANTED; HYPOXIA, BRAIN; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PROSENCEPHALON; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 3242744596     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/27.2.194     Document Type: Article

References (62)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
2. Chervin RD. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 2000;118:372-9.
3. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
4. Morisson F, Decary A, Petit D, Lavigne G. Malo J, Montplaisir J. Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest 2001;119:45-52.
5. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea:results of a meta-analysis. Arch Int Med 2003;163:565-71.
6. Bedard MA, Montplaisir J, Richer F, Malo J. Nocturnal hypoxemia as a determinant of vigilance impairment in sleep apnea syndrome. Chest 1991;100:367-70.
7. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996;109:1470-6.
8. Meurice JC, Paquereau J, Neau JP, Caron F, Dore P, Ingrand P, Patte F. Long-term evolution of daytime somnolence in patients with sleep apnea/hypopnea syndrome treated by continuous positive airway pressure. Sleep 1997;20:1162-6.
9. Aguillard RN, Riedel BW, Lichstein KL, Grieve FG, Johnson CT, Noe SL. Daytime functioning in obstructive sleep apnea patients:exercise tolerance, subjective fatigue, and sleepiness. Appl Psychophys Bio 1998;23:207-17.
10. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;164:939-43.
11. Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea:a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-8.
12. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978;44:931-8.
13. Tiihonen M, Partinen M. Polysomnography and maintenance of wakefulness test as predictors of CPAP effectiveness in obstructive sleep apnea. Electroencephalogr Clin Neurophysiol 1998;107:383-6.
14. Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep 2000;23:S102-8.
15. Dahlof P, Norlin-Bagge E, Hedner J, Ejnell H, Hetta J, Hallstrom T. Improvement in neuropsychological performance following surgical treatment for obstructive sleep apnea syndrome. Act Oto-Laryngol 2002;122:86-91.
16. Gozal D, Daniel JM, Dohanich GP. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci 2001;21:2442-50.
17. Row BW, Kheirandish L, Neville JJ, Gozal D. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002;52:449-53.
18. Row BW, Liu R, Wei X, Kheirandish L, Gozal D. Intermittent Hypoxia Is Associated with Oxidative Stress And Spatial Learning Deficits in the Rat. Am J Resp Crit Care Med 2003;167:1540-7.
19. Prabhakar NR, Fields RD, Baker T, Fletcher EC. Intermittent hypoxia: cell to system. Am J Phys 2001;281:L524-8.
20. Gu XQ, Haddad GG. Decreased neuronal excitability in hippocampal neurons of mice exposed to cyclic hypoxia. J Appl Physiol 2001;91:1245-50.
21. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001;21:4183-7.
22. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003;85:1394-1401.
23. Beal MF. Oxidatively modified proteins in aging and disease. Free Rad Bio Med 2002;32:797-803.
24. McGinty D, Szymusiak R. Hypothalamic regulation of sleep and arousal. Frontiers in Bioscience 2003;8:s1074-83.
25. Pace-Schott EF, Hobson JA. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nature Reviews Neuroscience 2002;3:591-605.
26. Veasey SC, Valladares O, Fenik P, et al. An automated system for recording and analysis of sleep in mice. Sleep 2000;23:1025-40.
27. Benington JH, Kodali SK, Heller HC. Scoring transitions to REM sleep in rats based on the EEG phenomena of pre-REM sleep:an improved analysis of sleep structure. Sleep 1994;17:28-36.
28. Veasey SC, Hsu Y-J, Thayer P, Fenik P. Murine multiple sleep latency test: phenotyping sleep propensity in mice. Sleep 2004, in press.
29. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.
30. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
31. Franken P, Chollet D, Tafti M. The homeostatic regulation of sleep need is under genetic control. J Neurosci 2001;21:2610-21.
32. Uryu K, Laurer H, McIntosh T, et al. Repetitive mild brain trauma accelerates A beta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neuroscience 2002;22:446-54.
33. Pratico D, Rokach J, Tangirala RK. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J Neurochem 1999;73:736-41.
34. Levine RL, Williams JA, Stadtman ER, Schacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 2000;233:346-57.
35. Frank J, Pompella A, Biesalski UK. Immunohistochemical detection of protein oxidation. Methods Mol Biol 2002;196:35-40.
36. Lorch SA, Foust R, Gow A, et al. Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrocysteine n a murine model of inhaled nitric oxide therapy. Pediatr Res 2000;47:798-805.
37. Gow AJ, McClelland M, Garner SE, Malcolm S, [schiropoulos II. The determination of nitrotyrosine residues in proteins. Methods Mol Biol 1998;100:291-9.
38. Zhan G, Shaheen F, Mackiewicz M, Fenik P, Veasey SC. Single cell laser dissection with molecular beacon polymerase chain reaction identifies 2A as the predominant serotonin receptor subtype in hypoglossal motoneurons. Neuroscience 2002;113:145-54.
39. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods 2000;98:9-20.
40. Heinzer R, Gaudreau H, Decary A, Sforza E, Petit D, Morisson F, Montplaisir J. Slow-wave activity in sleep apnea patients before and after continuous positive airway pressure treatment: contribution to daytime sleepiness. Chest 2001;119:1807-13.
41. Ling L, Fuller DD, Bach KB, Kinkead R, Olson EB Jr, Mitchell GS. Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing. J Neurosci 2001;21:5381-8.
42. Mitchell GS, Johnson SM. Neuroplasticity in respiratory motor control. J Appl Phys 2003;94:358-74.
43. Peng YJ, Prabhakar NR. Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Phys 2003;94:2342-9.
44. Takakura K, Beckman JS, MacMillan-Crow LA, Crow JP. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite. Arch Biochem Biophys 1999;369:197-207.
45. Josephs M, Katan M, Rodrigues-Lima F. Irreversible inactivation of magnesium-dependent neutral sphingomyelinase 1 (NSM1) by peroxynitrite, a nitric oxide-derived oxidant. FEBS Letters 2002;531:329-34.
46. van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase IB. Nature 2003;423:773-7.
47. Gow AJ, Ischiropoulos H. Nitric oxide chemistry and cellular signaling. J Cell Physiol 2001;187:277-82.
48. Ho YS, Liou HB, Lin JK, et al. Lipid peroxidation and cell death mechanisms in pulmonary epithelial cells induced by peroxynitrite and nitric oxide. Arch Toxicol 2002;76:484-93.
49. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2001;82:47-95.
50. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neurosci 2002;115:839-49.
51. Fuller DD, Johnson SM, Olson EB, Mitchell GS. Synaptic pathways to phrenic motoneurons are enhanced by chronic intermittent hypoxia after cervical spinal cord injury. J Neurosci 2003;23:2993-3000.
52. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-51.
53. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002;22:7695-711.
54. Graves LA, Hellman K, Veasey S, Blendy JA, Pack AI, Abel T. Genetic evidence for a role of CREB in sustained cortical arousal. J Neurophysiol 2003;90:1152-9.
55. Esposito F, Chirico G, Gesualdi NM, et al. Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires SRC activity. J Bio Chem 2003;278:20828-34.
56. Salmeen A, Andersen JN, Myers MP, et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003;423:769-73.
57. Starke DW, Chock PB, Mieyal JJ. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction. J Bio Chem 2003;278:14607-13.
58. Wendt S, Schlattner U, Wallimann T. Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues. J Bio Chem 2003;278:1125-30.
59. Klotz LO, Schroeder P, Sies H. Peroxynitrite signaling:receptor tyrosine kinases and activation of stress-responsive pathways. Free Rad Bio Med 2002;33:737-43.
60. Caselli RJ, Reiman EM, Hentz JG, Osborne D, Alexander GE, Boeve BF. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Sleep 2002;25:447-53.
61. Grace JB, Walker MP, McKeith IG. A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:1028-33.
62. Askenasy JJ. Sleep disturbances in Parkinsonism. J Neurol Trans 2003;110:125-50.